New York Presbyterian — New York, New York

New York Presbyterian is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Presbyterian has participated in 5 clinical trials.

Therapeutic areas: Structural Cardiac Defects, Acute Myeloid Leukemia, Paroxysmal Atrial Fibrillation.

Sponsors: RealView Imaging, Cephalon, Biosense Webster, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian?

New York Presbyterian has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian conducted?

New York Presbyterian has 5 clinical trials on record. Their work covers Structural Cardiac Defects, Acute Myeloid Leukemia, Paroxysmal Atrial Fibrillation.

Is New York Presbyterian accredited by Crixeo Health?

Yes — New York Presbyterian holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York Presbyterian?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.